Company information:
Neurocentrx Pharma Limited (No: SC454814)
Address: C/O MORTON FRASER LLP 2 LISTER SQUARE, QUARTERMILE TWO, EDINBURGH, EH3 9GL, SCOTLAND
Status: Active
Incorporated: 18-Jul-2013
Accounts Next Due: 31-Jul-2024
Next Confirmation Statement Due: 06-Aug-2024
Industry Class: 72110 - Research and experimental development on biotechnology
Current Director: GRAEME DUNCAN ( DOB: Nov-1974 From: Jun-2023 )
Current Director: SUSAN ELIZABETH FODEN ( DOB: Apr-1953 From: Jun-2021 )
Current Director: RONALD MCNAUGHT LINDSAY ( DOB: Nov-1947 From: Jan-2014 )
Current Director: FRASER STUART LUSTY ( DOB: Nov-1966 From: Jul-2015 )
Current Secretary: MORTON FRASER SECRETARIES LIMITED ( From: Apr-2017 )
Resigned Director: NIGEL STANLEY BROOKSBY ( From: Oct-2017 To: Jun-2019 )
Resigned Director: TIMOTHY HENRY CORN ( From: Oct-2017 To: Jun-2019 )
Resigned Director: OLEG DMITRIEV ( From: Mar-2014 To: Jul-2015 )
Resigned Director: SUSAN ELIZABETH FODEN ( DOB: Apr-1953 From: Jun-2021 To: Feb-2023 )
Resigned Director: HOWARD JOHN MARRIAGE ( DOB: Aug-1957 From: Nov-2013 To: Oct-2017 )
Resigned Director: CARMEL MARY REILLY ( DOB: Apr-1975 From: Jul-2013 To: Jun-2023 )
Resigned Director: HARRY THOMAS STRATFORD ( From: May-2015 To: Oct-2017 )
Resigned Secretary: MBM SECRETARIAL SERVICES LIMITED ( From: Jul-2013 To: Apr-2017 )
Persons of Significant Control:
Equity Gap Limited, 302 St Vincent Street St. Vincent Street, Glasgow, G2 5RZ, Scotland: Ownership of shares – More than 25% but not more than 50%, Ownership of voting rights - More than 25% but not more than 50% (Notified: 2016-04-06, Ceased: 2019-11-12)
Mr Fraser Stuart Lusty, Atrium Court, 50 Waterloo Street, Glasgow, G2 6HQ, Scotland: Has significant influence or control (Notified: 2016-04-06, Ceased: 2016-04-06)
Scottish Enterprise, Atrium Court, 50 Waterloo Street, Glasgow, G2 6HQ, Scotland: Ownership of shares – More than 25% but not more than 50%, Ownership of voting rights - More than 25% but not more than 50% (Notified: 2016-04-06)
Company Accounts Summary (£)
| Item | 16 | 17 | 19 | 20 | 21 | 22 | 23 | Chart |
|---|---|---|---|---|---|---|---|---|
| Fixed assets | 87,121 | 81,691 | 33,424 | 30,444 | 27,195 | 27,761 | 23,296 | 87121.0,81691.0,33424.0,30444.0,27195.0,27761.0,23296.0 |
| Fixed assets / Intangible assets | 84,732 | 79,483 | 32,993 | 29,994 | 26,995 | 23,996 | 20,997 | 84732.0,79483.0,32993.0,29994.0,26995.0,23996.0,20997.0 |
| Fixed assets / Property, plant and equipment | 2,389 | 2,208 | 431 | 450 | 200 | 3,765 | 2,299 | 2389.0,2208.0,431.0,450.0,200.0,3765.0,2299.0 |
| Current assets | 83,336 | 154,189 | 48,209 | 11,160 | 67,049 | 1,155,167 | 174,871 | 83336.0,154189.0,48209.0,11160.0,67049.0,1155167.0,174871.0 |
| Current assets / Total inventories | 23,375 | 15,125 | 23375.0,15125.0,0.0,0.0,0.0,0.0,0.0 | |||||
| Current assets / Debtors | 11,164 | 17,752 | 3,925 | 3,283 | 13,480 | 15,608 | 45,042 | 11164.0,17752.0,3925.0,3283.0,13480.0,15608.0,45042.0 |
| Current assets / Debtors / Trade debtors / trade receivables | 1,698 | 11,036 | 1698.0,11036.0,0.0,0.0,0.0,0.0,0.0 | |||||
| Current assets / Cash at bank and on hand | 48,797 | 121,312 | 44,284 | 7,877 | 53,569 | 1,139,559 | 129,829 | 48797.0,121312.0,44284.0,7877.0,53569.0,1139559.0,129829.0 |
| Net current assets (liabilities) | 60,612 | 145,033 | 37,896 | -15,425 | -205,315 | 1,079,463 | 105,138 | 60612.0,145033.0,37896.0,-15425.0,-205315.0,1079463.0,105138.0 |
| Equity / share capital and reserves | 226,724 | 71,320 | 15,019 | -323,747 | 658,731 | -320,059 | 0.0,226724.0,71320.0,15019.0,-323747.0,658731.0,-320059.0 |